Evaluation of Early Onset Sepsis, Complete Blood Count, and Antibiotic Use in Gastroschisis

Am J Perinatol. 2018 Mar;35(4):385-389. doi: 10.1055/s-0037-1607420. Epub 2017 Oct 30.

Abstract

Objective: Gastroschisis is a congenital defect in which the abdominal viscera herniate through the abdominal wall. In this population, antibiotics are often initiated immediately following delivery; however, this may be unnecessary as infections typically develop as a consequence of chronic issues in gastroschisis. The objective of this study was to evaluate the incidence of culture positive early onset sepsis, the reliability of the immature to mature neutrophil count (I:T) ratio as an infectious biomarker, and antibiotic use in infants with gastroschisis.

Study design: This retrospective chart review analyzed clinical data from 103 infants with gastroschisis and 103 weight-matched controls that were evaluated for early onset infection.

Results: Compared with the control group, there was a significantly increased percentage of infants with an I:T ratio > 0.2 in the gastroschisis group (43% vs. 12%, p < 0.001) and an increased percentage of infants exposed to greater than 5 days of antibiotics regardless of their I:T ratio (75% vs. 6%, p < 0.001). There were no episodes of culture positive early onset sepsis in either group.

Conclusion: Our results indicate that I:T ratio is not a reliable marker of infection in gastroschisis, and suggest that empiric septic evaluation and antibiotic use, immediately following delivery in gastroschisis infants, may be unnecessary.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Wall / pathology
  • Anti-Bacterial Agents / therapeutic use*
  • Blood Cell Count
  • Case-Control Studies
  • Female
  • Gastroschisis / complications*
  • Gastroschisis / drug therapy*
  • Humans
  • Infant, Newborn
  • Male
  • Neutrophils / cytology
  • Reproducibility of Results
  • Retrospective Studies
  • Sepsis / prevention & control*
  • United States

Substances

  • Anti-Bacterial Agents